A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...
Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...
In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
A multidisciplinary committee of experts studied the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine -- including human germline ...
New Haven, Conn. — The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing ...
Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA. Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark ...
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
Imagine that you could had the option to improve your reasoning skills and memory, not just with a cup of coffee but by editing your genome. Maybe even beyond that of today’s geniuses. And what if you ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果